奇士達控股(06918.HK):目前訂單未受疫情影響
被問到全球疫情爆發對玩具行業銷情的影響,玩具車生產商奇士達控股(06918.HK)投資者關係顧問黃馨逸表示,一般而言行業旺季為聖誕節假期,對疫情未感擔憂,又透露海外客戶集中在1月份及3至5月份下訂單,目前未見客戶有減少或延遲訂單。
他又表示,目前汕頭廠房復工情況合乎預期,產能恢復正常,期望利用上市集資所得擴展產能,以應付海外及國內客戶需求。
副總經理貝烈亮指,中美貿易戰明朗化,玩具產品雖被納入徵稅名單,但至今未實際實施過任何徵稅措施,相信公司銷售渠道覆蓋50多個國家地區,可分散風險,近期亦有拓展網上銷售渠道,預期電商平台銷售將錄得增長。(gc/K)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.